Literature DB >> 17880529

p63 expression in ovarian tumours: a marker for Brenner tumours but not transitional cell carcinomas.

X Y Liao1, W C Xue, D H Shen, H Y S Ngan, M K Siu, A N Cheung.   

Abstract

AIMS: To investigate p63 expression in ovarian neoplasms. METHODS AND
RESULTS: Immunohistochemistry using an antibody that detects all p63 isoforms was performed on 103 primary ovarian neoplasms of different histological types. Diffuse nuclear immunoreactivity of p63 was demonstrated in the 17 benign and five borderline Brenner tumours. Only one of the six malignant Brenner tumours displayed p63 expression. p63 immunoreactivity was absent in all the ovarian transitional cell carcinomas (TCC), but was demonstrated extensively in TCCs of the urinary bladder. Besides focal p63 expression in epidermal basal cells of immature and mature teratomas, all other ovarian lesions were devoid of p63 expression. p63 expression was also demonstrated in cervical transitional cell metaplasia and Walthard cell nests of fallopian tubes.
CONCLUSIONS: Expression of p63 protein is apparently cell lineage specific and in ovarian neoplasms is confined to benign and borderline Brenner tumours. The loss of expression in malignant Benner tumours suggests a role for p63 in Brenner carcinogenesis. The distinct patterns of p63 expression in TCCs in the ovary and urinary bladder may help in their differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880529     DOI: 10.1111/j.1365-2559.2007.02804.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Good survival in a patient with recurrent transitional cell carcinoma of the ovary: A case report of PET-CT for detection and follow-up.

Authors:  Jingquan Ma; Lijuan Yu; Xinghua Wang; G E Lou
Journal:  Oncol Lett       Date:  2015-05-20       Impact factor: 2.967

2.  Transitional cell carcinoma of the ovary (Review).

Authors:  Satoshi Ichigo; Hiroshi Takagi; Kazutoshi Matsunami; Takayuki Murase; Tsuneko Ikeda; Atsushi Imai
Journal:  Oncol Lett       Date:  2011-10-21       Impact factor: 2.967

3.  Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.

Authors:  Marcin P Iwanicki; Hsing-Yu Chen; Claudia Iavarone; Ioannis K Zervantonakis; Taru Muranen; Marián Novak; Tan A Ince; Ronny Drapkin; Joan S Brugge
Journal:  JCI Insight       Date:  2016-07-07

4.  Clonality analysis of combined Brenner and mucinous tumours of the ovary reveals their monoclonal origin.

Authors:  Yihong Wang; Ren-chin Wu; Lauren Ende Shwartz; Lisa Haley; Ming-tse Lin; Ie-ming Shih; Robert J Kurman
Journal:  J Pathol       Date:  2015-07-23       Impact factor: 7.996

5.  Malignant Brenner tumor of the ovary: Review and case report.

Authors:  Susan M Lang; Anne M Mills; Leigh A Cantrell
Journal:  Gynecol Oncol Rep       Date:  2017-07-03

6.  Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation.

Authors:  Xiaoyun Liao; Michelle K Y Siu; Christy W H Au; Esther S Y Wong; Hoi Yan Chan; Philip P C Ip; Hextan Y S Ngan; Annie N Y Cheung
Journal:  Carcinogenesis       Date:  2008-11-20       Impact factor: 4.944

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.